Potential role for P-glycoprotein in the nonproportional pharmacokinetics of UK-343,664 in man.

Autor: Abel, S., Beaumont, K. C., Crespi, C. L., Eva, M. D., Fox, L., Hyland, R., Jones, B. C., Muirhead, G. J., Smith, D. A., Venn, R. F., Walker, D. K.

Publikováno v: Xenobiotica; Aug/Sept2001, Vol. 31 Issue 8/9, p665-676, 12p, 1 Diagram, 1 Chart, 6 Graphs

Clinical analysis of sampatrilat, a combined renal endopeptidase and angiotensin-converting enzyme inhibitor II: Assay in the plasma and urine of human volunteers by dissociation enhanced lanthanide fluorescence immunoassay (DELFIA)

Autor: Venn, R. F., Barnard, G., Kaye, B., Macrae, P. V., Saunders, K. C.

Publikováno v: Journal of Pharmaceutical and Biomedical Analysis; 1998, Vol. 16 Issue: 5 p883-892, 10p

The preparation of stable enzyme-coenzyme complexes with endogenous catalytic activity

Autor: Gacesa, P, Venn, R F

Publikováno v: Biochemical Journal; January 1979, Vol. 177 Issue: 1 p369-372, 4p

Molecularly imprinted polymers for the determination of a pharmaceutical development compound in plasma using 96-well MISPE technology.

Autor: Chassaing C; Christophe Chassaing, Bioanalytical Group, Drug Metabolism, IPC 664, Pfizer Global Research and Development, Sandwich Laboratories, Ramsgate Road, Sandwich, Kent CT13 9NJ, UK. christophe_chassaing@sandwich.pfizer.com, Stokes J, Venn RF, Lanza F, Sellergren B, Holmberg A, Berggren C

Publikováno v: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences [J Chromatogr B Analyt Technol Biomed Life Sci] 2004 May 05; Vol. 804 (1), pp. 71-81.

Rapid, solid phase extraction technique for the high-throughput assay of darifenacin in human plasma.

Autor: Kaye B; Department of Drug Metabolism, Pfizer Central Research, Sandwich, Kent, U.K., Herron WJ, Macrae PV, Robinson S, Stopher DA, Venn RF, Wild W

Publikováno v: Analytical chemistry [Anal Chem] 1996 May 01; Vol. 68 (9), pp. 1658-60.